Excluding Vimedimex with a 50.1% yoy revenue drop since VMD specializes in drug distribution, 1Q22 aggregated revenue of 28 listed pharma producers climbed by 11.8% yoy, while aggregated net profit surged by 27.4% yoy. Looking forward to 2Q22F, demand for drugs could revive both through ETC (the drug channel for treatment, which patients can only buy at hospitals) and OTC (drugstores) when everything is back to normal. The demand for vitamins, antibiotics, and functional foods will expect to increase. The need for specific drugs used in hospitals will soon climb as hospitals start accepting patients again